Ispecimen Stock Analysis
ISPC Stock | USD 1.08 0.05 4.85% |
iSpecimen is undervalued with Real Value of 2.02 and Target Price of 5.0. The main objective of ISpecimen stock analysis is to determine its intrinsic value, which is an estimate of what iSpecimen is worth, separate from its market price. There are two main types of ISpecimen's stock analysis: fundamental analysis and technical analysis.
The ISpecimen stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ISpecimen's ongoing operational relationships across important fundamental and technical indicators.
ISpecimen | Build AI portfolio with ISpecimen Stock |
ISpecimen Stock Analysis Notes
The company has price-to-book (P/B) ratio of 1.61. Some equities with similar Price to Book (P/B) outperform the market in the long run. iSpecimen recorded a loss per share of 11.93. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 16th of September 2024. iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts. Ispecimen operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 59 people. To learn more about iSpecimen call Robert Lim at 781 301 6700 or check out https://ispecimen.com.ISpecimen Quarterly Total Revenue |
|
iSpecimen Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ISpecimen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding iSpecimen or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
iSpecimen generated a negative expected return over the last 90 days | |
iSpecimen has some characteristics of a very speculative penny stock | |
iSpecimen has high historical volatility and very poor performance | |
iSpecimen has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 9.29 M. Net Loss for the year was (12.5 M) with profit before overhead, payroll, taxes, and interest of 3.1 M. | |
iSpecimen currently holds about 23.69 M in cash with (8.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.67, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
iSpecimen has a frail financial position based on the latest SEC disclosures | |
Latest headline from gurufocus.com: Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change |
iSpecimen Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ISpecimen previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
12th of March 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
ISpecimen Largest EPS Surprises
Earnings surprises can significantly impact ISpecimen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2022-08-04 | 2022-06-30 | -0.27 | -0.3 | -0.03 | 11 | ||
2024-05-07 | 2024-03-31 | -0.27 | -0.32 | -0.05 | 18 | ||
2023-05-04 | 2023-03-31 | -0.32 | -0.27 | 0.05 | 15 |
ISpecimen Stock Institutional Investors
Shares | Bridgeway Capital Management, Llc | 2025-03-31 | 21.8 K | Ubs Group Ag | 2025-03-31 | 21.7 K | Geode Capital Management, Llc | 2025-03-31 | 10.7 K | Tower Research Capital Llc | 2025-03-31 | 3 K | Blackrock Inc | 2025-03-31 | 2.8 K | Bank Of America Corp | 2025-03-31 | 7.0 | Sbi Securities Co Ltd | 2025-03-31 | 2.0 | Sachetta Llc | 2025-03-31 | 2.0 | Fny Investment Advisers, Llc | 2024-12-31 | 0.0 | Jane Street Group Llc | 2024-12-31 | 0.0 |
ISpecimen Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.68 M.ISpecimen Profitablity
The company has Profit Margin (PM) of (1.4) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.55) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.55.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (3.11) | (2.95) | |
Return On Capital Employed | (3.56) | (3.38) | |
Return On Assets | (1.34) | (1.40) | |
Return On Equity | (3.77) | (3.59) |
Management Efficiency
iSpecimen has return on total asset (ROA) of (0.734) % which means that it has lost $0.734 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.6537) %, meaning that it created substantial loss on money invested by shareholders. ISpecimen's management efficiency ratios could be used to measure how well ISpecimen manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -2.95. The current year's Return On Capital Employed is expected to grow to -3.38. At present, ISpecimen's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 301 K, whereas Non Current Assets Total are forecasted to decline to about 4.4 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 4.66 | 4.89 | |
Tangible Book Value Per Share | (2.84) | (2.98) | |
Enterprise Value Over EBITDA | (0.03) | (0.03) | |
Price Book Value Ratio | 0.57 | 0.54 | |
Enterprise Value Multiple | (0.03) | (0.03) | |
Price Fair Value | 0.57 | 0.54 | |
Enterprise Value | 324.6 K | 308.4 K |
Effective leadership at ISpecimen drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Technical Drivers
As of the 20th of July, ISpecimen retains the Standard Deviation of 4.33, market risk adjusted performance of (0.14), and Risk Adjusted Performance of (0.03). ISpecimen technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.iSpecimen Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Simple Moving Average indicator is calculated by adding the closing price of ISpecimen for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out iSpecimen short-term fluctuations and highlight longer-term trends or cycles.
iSpecimen Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ISpecimen insiders, such as employees or executives, is commonly permitted as long as it does not rely on ISpecimen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ISpecimen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ISpecimen Outstanding Bonds
ISpecimen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. iSpecimen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ISpecimen bonds can be classified according to their maturity, which is the date when iSpecimen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
ISpecimen Predictive Daily Indicators
ISpecimen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ISpecimen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
ISpecimen Forecast Models
ISpecimen's time-series forecasting models are one of many ISpecimen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ISpecimen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About ISpecimen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how ISpecimen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ISpecimen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ISpecimen. By using and applying ISpecimen Stock analysis, traders can create a robust methodology for identifying ISpecimen entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (1.35) | (1.41) | |
Operating Profit Margin | (1.37) | (1.44) | |
Net Loss | (1.35) | (1.41) | |
Gross Profit Margin | 0.43 | 0.56 |
Current ISpecimen Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ISpecimen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ISpecimen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
5.0 | Strong Buy | 1 | Odds |
Most ISpecimen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ISpecimen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of iSpecimen, talking to its executives and customers, or listening to ISpecimen conference calls.
ISpecimen Stock Analysis Indicators
iSpecimen stock analysis indicators help investors evaluate how ISpecimen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ISpecimen shares will generate the highest return on investment. By understating and applying ISpecimen stock analysis, traders can identify ISpecimen position entry and exit signals to maximize returns.
Begin Period Cash Flow | 2.3 M | |
Total Stockholder Equity | 3.3 M | |
Capital Lease Obligations | 312.2 K | |
Property Plant And Equipment Net | 421.5 K | |
Cash And Short Term Investments | 1.9 M | |
Net Invested Capital | 3.3 M | |
Cash | 1.9 M | |
200 Day M A | 2.3555 | |
50 Day M A | 1.0928 | |
Net Interest Income | -175.9 K | |
Total Current Liabilities | 5.8 M | |
Investments | 2 M | |
Interest Expense | 220.1 K | |
Stock Based Compensation | 249.7 K | |
Common Stock Shares Outstanding | 710.9 K | |
Total Cashflows From Investing Activities | 2 M | |
Free Cash Flow | -8.3 M | |
Operating Income | -12.7 M | |
Other Current Assets | 264.9 K | |
Accounts Payable | 4.2 M | |
Net Debt | -1.6 M | |
Depreciation | 2.3 M | |
Other Operating Expenses | 22 M | |
Non Current Assets Total | 5.8 M | |
Liabilities And Stockholders Equity | 9.4 M | |
Non Currrent Assets Other | 12.1 K |
Complementary Tools for ISpecimen Stock analysis
When running ISpecimen's price analysis, check to measure ISpecimen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISpecimen is operating at the current time. Most of ISpecimen's value examination focuses on studying past and present price action to predict the probability of ISpecimen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISpecimen's price. Additionally, you may evaluate how the addition of ISpecimen to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |